Seguridad del embarazo posterior al trasplante de órganos sólidos: una revisión de alcance

Autores/as

  • Luciane Piva Klein Universidade Federal do Rio Grande do Sul – Hospital de Clínicas de Porto Alegre – Programa de Pós-Graduação em Assistência Farmacêutica – Porto Alegre (RS) – Brasil. https://orcid.org/0000-0001-5353-9446
  • Diego Gnatta Universidade Federal do Rio Grande do Sul – Hospital de Clínicas de Porto Alegre – Programa de Pós-Graduação em Assistência Farmacêutica – Porto Alegre (RS) – Brasil. https://orcid.org/0000-0002-1049-8899

Palabras clave:

Trasplante de Órganos, Revisión de Alcance, Salud Materno-Infantil, Inmunosupresores

Resumen

Objetivo: Realizar una revisión de alcance para identificar el seguimiento clínico del embarazo en mujeres sometidas a trasplantes de hígado, riñón, corazón y pulmón, con el fin de evaluar la seguridad de la gestación en este contexto. Metodología: Se trata de una revisión de alcance realizada mediante búsquedas en las bases de datos MEDLINE/PubMed, LILACS y SciELO, que incluyó estudios publicados entre 2014 y 2024. Resultados: Se incluyeron 45 estudios, seleccionados a partir de 1.206 registros. Se observó un predominio de publicaciones en los últimos cinco años (46%) y una mayor frecuencia de estudios sobre trasplante renal (77,7%). Los temas abordados incluyeron desenlaces maternos (hipertensión, preeclampsia y diabetes gestacional), desenlaces neonatales (prematuridad, bajo peso al nacer, abortos y malformaciones congénitas), perfil clínico y demográfico de las receptoras, regímenes de inmunosupresión, función del injerto, vía de parto, así como aspectos relacionados con la lactancia materna, planificación familiar, percepciones maternas, orientaciones para el equipo asistencial y gestaciones en hombres trasplantados. Conclusión: Los resultados demostraron que el embarazo posterior al trasplante es viable y seguro. De acuerdo con los estudios incluidos, los principales factores determinantes para la seguridad materno-fetal incluyen un intervalo adecuado entre el trasplante y la concepción, la planificación familiar, la función estable del injerto y el manejo adecuado de la terapia inmunosupresora. Esta revisión contribuye a orientar conductas clínicas basadas en la evidencia en el contexto del embarazo postrasplante.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. Global Observatory on Donation and Transplantation. Global Report 2023. Madrid; 2023. [access on 2025 Sep 28]. Available at: https://www.transplant-observatory.org/2023-global-report-%E2%80%8E/.

2. Fuchs KM, Coustan DR. Immunosuppressant therapy in pregnant organ transplant recipients. Semin Perinatol. 2007 Dec; 31(6): 363-371. https://doi.org/10.1053/j.semperi.2007.09.006.

3. Radaelli E, et al. Gestação após transplante renal: 40 anos de experiência em centro único. Braz J Nephrol. 2024; 46(2): e20230061. https://doi.org/10.1590/2175-8239-JBN-2023-0061pt.

4. Ministério da Saúde. Relatório de consulta pública: protocolo clínico e diretrizes terapêuticas – imunossupressão no transplante renal. Brasília: Conitec; 2020. [access on 2025 Oct 2]. Available at: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2020/relatorio_pcdt_imunossupressao_em_transplante_renal_cp_28_2020.pdf.

5. Wise A, et al. Pregnancy after kidney and liver transplantation. S Afr Med J. 2024 Apr; 114 (3b): e1240. https://doi.org/10.7196/SAMJ.2024.v114i3b.1240.

6. Murray JE, Reid DE, Harrison JH, Merrill JP. Successful pregnancies after human renal transplantation. N Engl J Med. 1963 Aug; 269(7): 341-343. https://doi.org/10.1056/NEJM196308152690704.

7. Surita FG, Guida JPS, Juliato CR, Boin IF. Gestação e planejamento reprodutivo em mulheres transplantadas. Braz J Transplant. 2023; 26(1): e3623. https://doi.org/10.53855/bjt.v26i1.542_PORT.

8. Yo JH, et al. Adverse pregnancy outcomes in solid organ transplant recipients: a systematic review and meta-analysis. JAMA Netw Open. 2024 Aug; 7(8): e2430913. https://doi.org/10.1001/jamanetworkopen.2024.30913

9. Tricco AC, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016 Feb; 16 (15). https://doi.org/10.1186/s12874-016-0116-4.

10. Tricco AC, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018 Sep; 169 (7): 467-473. https://doi.org/10.7326/M18-0850.

11. Kubo S, Uemoto S, Furukawa H, Umeshita K, Tachibana D; Japanese Liver Transplantation Society. Pregnancy outcomes after living donor liver transplantation: results from a Japanese survey. Liver Transpl. 2014 May; 20 (5): 576-583. https://doi.org/10.1002/lt.23837.

12. Mohamed-Ahmed O, et al. Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study. PLoS One. 2014 Feb; 9(2): e89151. https://doi.org/10.1371/journal.pone.0089151.

13. Rafie S, Lai S, Garcia JE, Mody SK. Contraceptive use in female recipients of a solid-organ transplant. Prog Transplant. 2014 Dec; 24(4): 344-348. https://doi.org/10.7182/pit2014426.

14. Rupley DM, Janda AM, Kapeles SR, Wilson TM, Berman D, Mathur AK. Preconception counseling, fertility, and pregnancy complications after abdominal organ transplantation: a survey and cohort study of 532 recipients. Clin Transplant. 2014 Jun; 28(9): 937-945. https://doi.org/10.1111/ctr.12393.

15. Songin T, et al. Pregnancy after kidney and liver transplantation: its outcome and effect on the graft, mother, and neonate. Ann Transplant. 2014 Dec; 19: 660-666. https://doi.org/10.12659/AOT.892232.

16. Westbrook RH, et al. Outcomes of pregnancy following liver transplantation: the King’s College Hospital experience. Liver Transpl. 2015 Sep; 21 (9): 1153-1159. https://doi.org/10.1002/lt.24182.

17. Candido C, et al. Gestação após o transplante renal: alto índice de complicações maternas. J Bras Nefrol. 2016 Dec; 38 (4):421-426. https://doi.org/10.5935/0101-2800.20160067.

18. Li Y-P, Shih J-C, Lin S-Y, Lee C-N. Pregnancy outcomes after kidney transplantation: a single-center experience in Taiwan. Taiwanese J Obstet Gynecol. 2016 Jun; 55(3): 314-318. https://doi.org/10.1016/j.tjog.2016.04.004

19. Majak GB, et al. Pregnancy outcomes following maternal kidney transplantation: a national cohort study. Acta Obstet Gynecol Scand. 2016 Jun; 95(10): 1153-1161. https://doi.org/10.1111/aogs.12937.

20. Mishra VV, Nanda SS, Mistry K, Choudhary S, Aggarwal R, Vyas BM. An overview on fertility outcome in renal transplant recipients. J Obstet Gynaecol India. 2016 Jun; 66 (Suppl 1): 330-334. https://doi.org/10.1007/s13224-016-0919-6.

21. Rose C, Gill J, Zalunardo N, Johnston O, Mehrotra A, Gill JS. Timing of pregnancy after kidney transplantation and risk of allograft failure. Am J Transplant. 2016 Aug; 16 (8): 2360-2367. https://doi.org/10.1111/ajt.13773.

22. Stoumpos S, et al. Obstetric and long-term kidney outcomes in renal transplant recipients: a 40 year single-centre study. Clin Transplant. 2016 Mar; 30 (6): 673-681. https://doi.org/10.1111/ctr.12732.

23. Amine BHH, Haythem S, Kais H, Radhouane R. Pregnancy after renal transplantation: a retrospective study at the military hospital of Tunis from 1992 to 2011. Pan Afr Med J. 2017; 28 (137). https://doi.org/10.11604/pamj.2017.28.137.6287.

24. King KW, Baca MJ, Armenti VT, Kaplan B. Pregnancy outcomes related to mycophenolate exposure in female kidney transplant recipients. Am J Transplant. 2017 Jan; 17 (1): 151-160. https://doi.org/10.1111/ajt.13928.

25. Majak GB, et al. Preeclampsia in kidney transplanted women: outcomes and a simple prognostic risk score system. PLoS One. 2017 Mar; 12 (3): e0173420. https://doi.org/10.1371/journal.pone.0173420.

26. Mattila M, Kemppainen H, Isoniemi H, Polo-Kantola P. Pregnancy outcomes after liver transplantation in Finland. Acta Obstet Gynecol Scand. 2017 Jun; 96 (9): 1106-1111. https://doi.org/10.1111/aogs.13175.

27. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A. Exposure to mycophenolate and fatherhood. Transplantation. 2017 Jul; 101 (7): e214-e217. https://doi.org/10.1097/TP.0000000000001747.

28. Piccoli GB, et al. Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies a multicenter Nationwide analysis. Transplantation. 2017 Oct; 101 (10): 2536-2544. https://doi.org/10.1097/TP.0000000000001645.

29. Bry C, et al. Pregnancy after lung and heart–lung transplantation: a French multicentre retrospective study of 39 pregnancies. ERJ Open Res. 2019; 5 (4): 00254-2018. https://doi.org/10.1183/23120541.00254-2018.

30. Yoshikawa Y, Uchida J, Akazawa C, Suganuma N. Associations between physical and psychosocial factors and health-related quality of life in women who gave birth after a kidney transplant. Int J Womens Health. 2018 Jun; (10): 299-307. https://doi.org/10.2147/IJWH.S152750.

31. Al-Otaibi T, et al. Pregnancy after renal transplant: single center experience from the Middle East in patients using different calcineurin inhibitors. Exp Clin Transplant. 2019 Jan; 17 (Suppl 1): 99-104. https://doi.org/10.6002/ect.MESOT2018.O42.

32. Bachmann F, et al. Pregnancy following kidney transplantation: impact on mother and graft function and focus on childrens’longitudinal development. BMC Pregnancy Childbirth. 2019 Oct; 19 (376). https://doi.org/10.1186/s12884-019-2496-z.

33. Mariano S, et al. Pregnancy among women with kidney transplantation: a 20-year single-center registry. Rev Bras Ginecol Obstet. 2019 Aug; 41(7): 419-424. https://doi.org/10.1055/s-0039-1688834

34. Yun BH, Joo DJ, Seo SK, Cho SH, Choi YS, Lee BS. Effect of deflazacort on pregnancy outcome in kidney transplant patients: should we change the immunosuppressant before conception? BMC Nephrol. 2019 May; 20 (161). https://doi.org/10.1186/s12882-019-1346-6.

35. Borek-Dziecioł B, et al. Selected biochemical parameters in children of mothers after kidney transplantation. Transplant Proc. 2020 Oct; 52 (8): 2294-2298. https://doi.org/10.1016/j.transproceed.2020.02.100.

36. Naya I, et al. Pregnancy outcomes following pediatric liver transplantation: a single-center experience in Japan. Ann Transplant. 2020 Jun; 25: e921193. https://doi.org/10.12659/AOT.921193.

37. Romeo JLR, et al. Influence of pregnancy on long-term durability of allografts in right ventricular outflow tract. J Thorac Cardiovasc Surg. 2020 Apr; 159 (4): 1508-1516. https://doi.org/10.1016/j.jtcvs.2019.08.083.

38. Sivaprasadan S, Mathew JS, Surendran S, Padma UD. Pregnancy after liver transplantation: outcomes from a single-center experience. J Clin Exp Hepatol. 2020 Jul-Aug; 10 (4): 329-333. https://doi.org/10.1016/j.jceh.2019.10.002.

39. Koenjer LM, et al. Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study. Transpl Int. 2021 Nov; 34 (12): 2669-2679. https://doi.org/10.1111/tri.14156.

40. Marzec I, et al. Pregnancy after liver transplant: maternal and perinatal outcomes. BMC Pregnancy Childbirth. 2021 Sep; 21 (627). https://doi.org/10.1186/s12884-021-04104-w.

41. van Buren MC, Beck DK, Lely AT, van de Wetering J, Massey EK. EXPloring attitudes and factors influencing reproductive choices in kidney transplant patients (The EXPECT-study). Clin Transplant. 2021 Aug; 35 (12): e14473. https://doi.org/10.1111/ctr.14473.

42. Yin O, et al. Mode of obstetric delivery in kidney and liver transplant recipients and associated maternal, neonatal, and graft morbidity during 5 decades of clinical practice. JAMA Netw Open. 2021 Oct; 4(10): e2127378. https://doi.org/10.1001/jamanetworkopen.2021.27378.

43. Bedin A, et al. Pregnancies and gynecological follow-up after solid organ transplantation: experience of a decade. J Clin Med. 2022 Aug; 11 (16): 4792. https://doi.org/10.3390/jcm11164792.

44. Gosselink ME, et al. A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int. 2022 Oct; 102 (4): 866-875. https://doi.org/10.1016/j.kint.2022.06.006.

45. Hewawasam E, et al. Determinants of perinatal outcomes in dialyzed and transplanted women in Australia. Kidney Int Rep. 2022 Jun; 7 (6): 1318-1331. https://doi.org/10.1016/j.ekir.2022.03.015.

46. Schwarz A, et al. Graft function and pregnancy outcomes after kidney transplantation. BMC Nephrol. 2022 Jan; 23 (27). https://doi.org/10.1186/s12882-022-02665-2.

47. van Buren M, et al. Effect of pregnancy on eGFR after kidney transplantation: a national cohort study. Transplantation. 2022 Jun; 106 (6): 1262-1270. https://doi.org/10.1097/TP.0000000000003932.

48. Chung K, et al. Emergent prelabor cesarean delivery in solid organ transplant recipients: associated risk factors and outcomes. Am J Obstet Gynecol MFM. 2023 Feb; 5 (2): 100799. https://doi.org/10.1016/j.ajogmf.2022.100799.

49. Craig AM, et al. Maternal and pregnancy outcomes following heart transplantation in the United States. JACC Heart Fail. 2023 Oct; 11 (12): 1666-1674. https://doi.org/10.1016/j.jchf.2023.08.018.

50. Oki R, et al. Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. Transpl Int. 2023 May; 36: 11220. https://doi.org/10.3389/ti.2023.11220.

51. Stavart L, et al. Pregnancy after kidney transplantation: an observational study on maternal, graft and offspring outcomes in view of current literature. Front Nephrol. 2023 Jul; 3: 1216762. https://doi.org/10.3389/fneph.2023.1216762.

52. Schagen MR, et al. Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: a retrospective cohort study. Br J Clin Pharmacol. 2024; 90 (1): 176-188. https://doi.org/10.1111/bcp.15886.

53. Szpotanska-Sikorska M, et al. Family planning and assessment of the frequency of exposure to drugs contraindicated in pregnancies after kidney or liver transplantation: a retrospective cross-sectional study. Transplant Proc. 2024 May; 56 (4): 912-915. https://doi.org/10.1016/j.transproceed.2024.03.011.

54. Yin O, Coscia L, Constantinescu S, Moritz MJ, Afshar Y, Irani RA. Pregnancy after deceased donor vs living donor kidney transplant: associated obstetric and graft outcomes. Am J Obstet Gynecol. 2024 Feb; 230 (2): 256.e1-256. https://doi.org/10.1016/j.ajog.2023.08.009.

55. Associação Brasileira de Transplante de Órgãos, Registro Brasileiro de Transplantes. Dimensionamento dos transplantes no Brasil e em cada estado (2016-2023). São Paulo: ABTO, RBT; 2023. 88 p. [access on 2025 Nov 16]. Available at: https://site.abto.org.br/wp-content/uploads/2024/03/RBT_2023-Populacao_Site.pdf.

56. Constantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT. Breastfeeding after solid organ transplantation. Best Pract Res Clin Obstet Gynaecol. 2014 Nov; 28(8): 1163-1173. https://doi.org/10.1016/j.bpobgyn.2014.09.001.

57. Society for Maternal-Fetal Medicine Publications Committee. Prepregnancy evaluation and pregnancy management of patients with solid organ transplants (SMFMC #66). 2023 Aug; B10-B32. https://doi.org/10.1016/j.ajog.2023.04.022

58. Rytz CL, et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and metaanalysis. Clin J Am Soc Nephrol. 2022 Dec;17 (12): 1742-1753. https://doi.org/10.2215/CJN.07100622.

59. Palmer BF. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther. 2003 Jan; 10(1): 48-60. https://doi.org/10.1053/jarr.2003.50003.

60. Parolin MB, Coelho JCU, Balbi E, Wiederkehr JC, Anghinoni M, Nassif AE. Normalização dos ciclos menstruais e gravidez após transplante de fígado. Arq Gastroenterol. 2000 Jan; 37 (1): 3-6. https://doi.org/10.1590/S0004-28032000000100002.

61. Coffin CS, Shaheen AA, Burak KW, Myers RP. Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case-control analysis. Liver Transpl. 2010 Jan; 16 (1): 56-63. https://doi.org/10.1002/lt.21906.

62. Kociszewska-Najman B, et al. Low transfer of tacrolimus and its metabolites into colostrum of graft recipient mothers. Nutrients. 2018 Feb; 10 (3) :267. https://doi.org/10.3390/nu10030267.

63. Zheng S, et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol. 2013 Mar; 76 (6): 988-996. https://doi.org/10.1111/bcp.12122.

64. Agência Nacional de Vigilância Sanitária. Risco de teratogenicidade - Novos aconselhamentos sobre a prevenção de gravidez para mulheres e homens em tratamento com CellCept® (micofenolato de mofetila). São Paulo; 2015. [access on 2025 Nov 16]. Available at: https://www.gov.br/anvisa/pt-br/assuntos/fiscalizacao-e-monitoramento/cartas-aos-profissionais-desaude/2017/cellcept-r-micofenolato-de-mofetila-risco-de-teratogenicidade-e-orientacoes-para-a-prevencao-de-gravidezroche11-de-dezembro-de-2015.

65. Ministério da Saúde. Brasil é o segundo maior transplantador de órgãos do mundo. Brasília; 2022 [access on 2025 Nov 16]. Available at: https://www.gov.br/saude/pt-br/assuntos/noticias/2022/fevereiro/brasil-e-o-segundo-maior-transplantadorde-orgaos-do-mundo.

Publicado

2026-06-26

Cómo citar

1.
Klein LP, Gnatta D. Seguridad del embarazo posterior al trasplante de órganos sólidos: una revisión de alcance. bjt [Internet]. 26 de junio de 2026 [citado 19 de octubre de 2026];29. Disponible en: https://bjt.emnuvens.com.br/revista/article/view/782

Número

Sección

Artículo de Revisión